title: Pertuzumab Use in the Adjuvant Setting: Why Not?
authors.affiliation: Aleix Prat, Hospital Clinic of Barcelona, and August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
authors.forename: Aleix
authors.initials: A
authors.lastname: Prat
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008495:Medical Oncology; D009864:Ontario; D018719:Erb-b2 Receptor Tyrosine Kinases; D014481:United States
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human; C485206:pertuzumab